Category Archives: Healthcare Professionals

Will the Catholic Church & the U.S. Courts Embrace Advanced Cell Technologies “Embryo-Safe” Technique Using Embryonic Stem Cells?

Advanced Cell Technology with laboratory facilities in Marlborough Massachusetts has pioneered a solution to the ethical, moral & legal debate raging in regards to protection of a human embryo. ACT has developed the “single-blastomere” technique. Patent Number 7,893,315 a non-destructive alternative for deriving human embryonic stem cell (hESC) lines.

This achievement in Regenerative medicine is a ground breaking feat for both Catholic and U.S. law.
• The 1995 encyclical The Gospel of Life, of which Pope John Paul II wrote: “Human embryos obtained in vitro are human beings and are subjects with rights; their dignity and right to life must be respected from the first moment of their existence. It is immoral to produce human embryos destined to be exploited as disposable ‘biological material'” (1,5 )
• The Dickey Amendment (also known as the Dickey-Wicker Amendment) is the name of an appropriation bill rider attached to a bill passed by United States Congress in 1995, and signed by former President Bill Clinton, which prohibits the Department of Health and Human Services (HHS) from using appropriated funds for the creation of human embryos for research purposes or for research in which human embryos are destroyed.

The single-blastomere technology uses a one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential. The stem cells generated using this approach are healthy, completely normal, and differentiate into all the cell types of the human The safety record for one-cell biopsy as part of PGD now has a 15-year track record, and is carried out routinely as part of IVF processes around the world. ACT’s technique of protecting the human embryo from harm can be expounded to the smallest blood transfusion in the world. As does a human being give millions of blood cells in a pint of blood so does ACT’s “single blastomere” process take but “one cell” from a 2 day old embryo. As the blood removed from a human donor “regenerate” the removed pint of blood so does the human embryo “regenerate” the one cell. Both of these procedures leave the human body & two day old embryo healthy. Both procedures are similar in that they both provide life saving material to those whom need them most to due to disease and other aliments of a medical nature.

Via EPR Network
More Healthcare press releases

Global Health Progress Releases Non-Communicable Diseases Partnerships and Programs List

Global Health Progress compiled a list of non-communicable disease treatment programs from around the world, highlighting partnerships to address cancer treatment, diabetes care, epilepsy programs and more. The programs, sponsored by leading companies like Astra Zeneca, Abbott, Novo Nordisk, and Bayer Healthcare, aim to increase awareness of non-communicable diseases in the developing world.

“Our goal in creating this list is to bring awareness to these companies who work so hard at fighting diseases in developing countries,” explains Mark Grayson, Vice President of Communications and Public Affairs at PhRMA and key developer in the Global Health Progress initiative. “Non-communicable diseases are the leading killer in many of these countries, and without the help of these programs they would continue to increase.”

Global Health Progress works with partner groups to encourage and sustain funding for the research and development of healthcare in developing nations. Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

Read the full list of non-communicable disease treatment programs here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/NCD-Health-Partnerships-and-Programs_Worldwide-05-02-11.pdf.

Via EPR Network
More Healthcare press releases

Side by side comparison of Advanced Cell Technology & Geron Corporation

Regenerative medicine is a highly complicated and vastly misunderstood science. Investor Stem Cell is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible advancements unfolding in the regenerative medicine sector. A quantum leap in health care is upon the world. Will you profit from this emerging sector & help bring cures to millions? Find out now what the street thinks at www.investorstemcell.com.

Side by side comparison of Advanced Cell Technology & Geron Corporation:

Geron Corporation (NASDAQ:GERN), Approved by the FDA to use human embryonic stem cell (hESC) treatments to treat spinal cord injuries. The research Goliath is a well-funded machine employing the top minds in the world working on everything from mid-stage oncology trials to promising (hESC) drugs for spinal cord injuries, heart disease & cancer.

Snap shot of Goliath: Geron Corpoartion-(NASDAQ:GERN)-
• Seven oncology Phase 2 trials currently underway, and has several big Pharma joint venture agreements in oncology animal and human trials
• Five hESC areas of investigation underway. GRNOPC1 is the lead candidate. Geron destroys the human embryo through its (hESC) R&D, of which the company uses the blastocyst embryo formation at day five after fertilization from IVF clinics
• Cash, restricted cash, cash equivalents and marketable securities: $221,274.000.00
• Total operating expenses in 2010: $114,730,000.00
• 175 employees; over 100 hold PhD or MD degrees
• Geron Corporation was founded in 1990 and is based in Menlo Park, California
• Trades on the NASDAQ providing liquidity & large institutional investors
• Corporate financial statements:http://www.geron.com/investors/reports/GeronAnnualReport2010.pdf

Advanced Cell Technology not too long ago was the predominant leader in the field of regenerative medicine. It fell from that distinction in part due to executive management hubris and ultimately the credit crisis in mid-2008. ACT was able to resurrect itself from near bankruptcy in June 2008 and now has the distinction of holding two out of the three FDA approved (hESC) trials. ACT is led by a competent executive management team and employs several of the most predominant regenerative researcher(s) in the world.

Snap shot of David: Advanced Cell Technology-(OTC:ACTC)-
• Retinal Pigment Epithelial Cell Program is their lead program-(HESC) trials for both SMD/AMD are expected to start in week(s) Jules Stein Eye Institute at the University of California, Los Angeles (UCLA ) will conduct the 2 (hESC) trials for Stargardt’s Macular Dystrophy (SMD) and Dry Age-Related Macular Degeneration (AMD)
• Filed a European Clinical Trial Application for Phase 1/2 study using (hESC) to treat macular degeneration
• Issued a broad patent for hESC-derived RPE cells in China
• Seeking funding & joint venture partner for Myoblast program for the treatment of cardiovascular disease Phase 2 approved by the FDA
• Joint ventured with Korean medical giant CHA to form “Stem Cell & Regenerative Medicine International” (SCRMI). This partnership expected to file an investigational new drug application (IND) with the FDA in Q-4 of this year. CHA biotech is waiting for final approval from the Korea Food and Drug Administration for (hESC) trial for AMD
• Issued patent on its “single-blastomere” technique. Patent Number 7,893,315 broadly covers ACT’s proprietary single-blastomere technology that provides a non-destructive alternative for deriving hESC lines. This “Embryo-Safe” one-cell biopsy approach similar to pre-implantation genetic diagnosis (PGD), which is widely used in the in vitro fertilization (IVF) process and does not interfere with the embryo’s developmental potential
• 22 full-time employees, six hold PhD or MD degrees-Formed in 1994, HQ in Menlo Park, California with laboratory facilities in Marlborough, MA
• Total operating expenses in 2010: $22,044,701
• Cash, restricted cash, cash equivalents and marketable securities: $34,889,409
• Trades on the OTC:BB ACTC is a Sarbanes–Oxley Act SEC reporter
• Corporate financial statements: http://www.sec.gov/Archives/edgar/data/11...

Via EPR Network
More Healthcare press releases

The Harley Medical Group reports rise in procedure dubbed ‘The Cameron’

Thinning lips are common problem amongst 40-something successful men, such as PM David Cameron, as aging and stress take their toll by reducing collagen production, which is responsible for keeping lips full and youthful. But British men are not happy with the “thin upper lip” look, and according to the UK’s leading cosmetic injectable company, The Harley Medical Group, are opting for dermal filler procedures to boost top and bottom lips. The Group reports male lip enhancing treatments are up 17% for the first quarter year on year – a procedure which has been dubbed by practioners at the Group’s Harley Street clinic The Cameron.

Says Lisa Littlehales, Specialist Nurse Councellor at The Harley Medical Group:“Whilst there is no doubt that the PM’s lips have thinned, his thinning lips are less noticeable in many ways, as he had incredibly slim line lips with minimal lip arches to begin with, but thinning lips are a common problem for men of his age group. A full lip line is central to presenting a youthful appearance and once ageing sets in, thinning lips can be very aging. We have seen more and more men opt for treatment, booking in for 30 minute sessions to have their upper and bottom lips boosted with non permanent fillers. ”

Dubbed ‘The Cameron’, the lip filler treatment costs from £350 at The Harley Medical Group and requires topping up every 3- 6months to help to restore a youthful plumpness to the lips. The filler is administered in a series of small injections on each side of the lips over a half hour treatment time, giving natural, immediate results. There is no downtime to the treatment, making this the perfect treatment for 40-something busy men.

Liz Dale, Director at The Harley Medical Group adds: “Cosmetic treatments for men, such as lip fillers to help combat the effects of ageing, is a trend which has become increasingly popular across our 31 clinics, with men feeling more comfortable to book in for treatments and the idea of cosmetic injectable treatments for men becoming more acceptable than it was five years ago”.

Via EPR Network
More Healthcare press releases

Obesity Solutions International Retains Three New Bariatric Surgeons

Obesity Solutions International, LLC adds three new bariatric surgeons to boost bariatric surgery services in Tijuana, Mexico. Three new physicians, Dr. Pablo Romero, Dr. Fernando Garcia and Dr. Alejandro Lopez, will join the staff of Obesity Solutions International in Tijuana, Mexico.

“With the addition of three new surgeons, our surgeons grow from four to seven; and we expand from offering surgeries in Monterrey, Mexico, Guadalajara, Mexico and Mexicali, Mexico to include Tijuana, Mexico,” the manager of Obesity Solutions International says. The new physicians will receive warm welcomes from, Dr. Fronseca, Dr. Zapata, Dr. Martin Lopez, and Dr. Jaime Romos-Kelly, the physicians Obesity Solutions International currently works with:

“As our staff, and cities we operate continue to expand, we are out-competing with our competitors in services offered. Not many companies can provide the flexibility of multiple cities with multiple doctors. We are truly a patient-focused business. And we will always stay that way,” the director adds.

New Bariatric Physicians in Tijuana, Mexico:

Dr. Pablo Romero is a general surgeon with high levels of experience in bariatric surgery. He is a medical doctor whose done extensive training in bariatrics. He’s studied at a myriad of Universities including UNAM Mexico City and University of California, San Diego. He formerly worked under Dr. Ariel Ortiz, a renown bariatric surgeon seen on the Dr. Phil Show. Along with his two Masters Degrees Dr. Romero has the technical skills and experience to provide excellent patient care in Tijuana, Mexico.

Dr. Fernando Garcia is a physician that specializes in bariatric surgery. Dr. Garcia has a wealth of experience in patient-care, as he has worked in numerous hospitals in Tijuana, Mexico. Currently, he is working for, or on-call to, four hospitals in Tijuana, Mexico. Dr. Garcia has advanced education, including courses in gastric sleeve, lap-band, laparascopic surgery and more. Combining his compassion for patients and his academic drive, makes Dr. Garica a well-respected bariatric surgeon.

Dr. Alejandro Lopez is a general surgeon, who is committed to advancing medicine. He is a member to four medical associations including, the Mexico Association of Endoscopic Surgery and Mexico College of Obesity Surgery. When Dr. Lopez is not working, or continuing his education, he is researching medicine and getting published in index magazines. His profound admiration for medicine, education and academia will serve him well in helping people lose weight.

Via EPR Network
More Healthcare press releases

From Universal HIV Testing to HIV Cure

People involved in the fight against HIV/AIDS will gather in Marseille, France, May 23-25, 2012 for an international AIDS Conference under the theme: ‘From Universal HIV Testing to HIV Cure’.

The ISHEID (International Symposium on HIV & Emerging Infectious Diseases) is a major scientific event attracting doctors, biologists, researchers, patients’ representatives and policy makers from all around the world. Its next edition, to be held just more than one year ahead, will focus on recent developments against this pandemic.

Despite major advances in antiretroviral therapy, HIV still infects daily 2,000 new individuals and kills 2 millions each year. Current treatments are life-long with problems of compliance, resistance, toxicity, access, and cost.

‘There are advances both in the area of prevention, testing and potential cure’ told Alain Lafeuillade, a French Doctor involved in the organization of the conference. ‘Our driving force is to draw to the conference the best experts in the world for each program theme’. Antiretroviral treatment as prevention (or pre-exposure prophylaxis) will be debated with the pros and cons. Human rights and access to HIV care will be the focus of en entire session. Current issues in antiretroviral therapy management will be discussed during 2 sessions. Finally, the best American experts in the field of HIV reservoirs and eradication research will present their latest discoveries in the search for a cure.

The international Steering Committee will actively build a program the most exciting possible in the forthcoming months. Meanwhile, interviews of renowned experts are regularly published on the meeting website: http://www.isheid.com/en/committees/interview.html

Via EPR Network
More Healthcare press releases

New Website Dedicated To Stem Cell Investors

Investor Stem Cell (http://www.investorstemcell.com) is dedicated to bringing investors and stakeholders together in thoughtful discussion to educate and publicize the incredible medical advancements taking place in the regenerative medicine sector. Scientists are using stem cells both (hESC) and (iPSC) in hopes of easing the suffering of hundreds of millions of people world wide.

Our society is on the verge of a quantum leap moment in time thanks to regenerative medicine.

Regenerative medicine and Stem Cell research:

Utter those words at your next dinner party or casual gathering of friends and family. You will receive a concoction of half-truth’s and out right fallacy responses. Stem Cell research conjures images of futuristic Star–Trek like preservation chambers, human looking ears protruding oddly from the backs of mice, or worse yet an image of a late term fetus. Nothing could be farther from the truth when entering the reality of Regenerative medicine.

Never before has this area of research been more exciting and promising than right now. There is a medical revolution brewing, and like any revolution, there are those who want to suppress this uprising for continued personal and ideological gains. If we were to take all the major advances in the past 500 years of human medical history and multiply its effect by 10 fold it still would not compare to the paradigm shift in health care delivery that the world may witness in this decade using stem cells. Imagine that an $800,000 heart transplant is no longer needed and that instead the same money spent on one patient can now be stretched out to treat 20 patients who are needing a heart transplant. Is this what Regenerative medicine has in the offing? Only time will tell. Our healthcare system could very well be on the verge of a quantum leap moment thanks to regenerative medicine.

The Food and Drug Administration (FDA) authorized 3 trials using human embryonic stem cells (hESC) in late 2010. Validation of hESC research efforts and the culmination of billions spent on research are coming to fruition. FDA validation for the treatments of spinal cord injury and age related macular degeneration is expected in 2011. It may be the shot heard around the world event sometime in late Q-4 2011 for the Regenerative medicine sector.

Via EPR Network
More Healthcare press releases

Medelita medical coats feature state of the art fabrics and durable design features

Medelita®, maker of breakthrough performance medical coats for both men and women, offers the best selection for those medical professionals who are looking for functional, professional appearing coats. Featuring state of the art materials and smart, flattering designs, Medelita continues to push above and beyond the competition in order to offer medical professionals the very best quality and selection in the medical uniform market.

Medelita medical coats are made from pre-shrunk, 100% cotton textured fabric, which allow for a soft, sophisticated finish that is immediately noticeable. While most medical coats are unisex in styling, Medelita coats are contoured gender specifically for men and women, creating a durable and functional fitting garment that remains comfortable throughout the work day. The overall dimensions and styling of the medical coats are specifically designed to allow for ample forward reach without limiting range of motion in the arms, shoulders, or neck. In addition, Medelita coats also offer modern features like women’s rounded lapels and men’s blazer chest pockets.

As medical professionals wear medical coats in high pressure, stressful situations, Medelita medical coats use breathable 100% cotton fabric that features High-IQ Easy Care Plus wrinkle resistance and Advanced Dual Action Teflon fabric stain protector, the latter of which allows fluids to simply run right off the fabric.

Via EPR Network
More Healthcare press releases

Medelita partners with the Society for Dermatology Physician Assistants

Medelita®, maker of breakthrough performance lab coats for both men and women, announces a new partnership with the Society of Dermatology Physician Assistants. Member benefit discount and affiliation agreement begin on May 1st.

The Society of Dermatology Physician Assistants is a non-profit professional organization comprised of individuals who provide dermatologic care, or have expressed interest in the field of dermatology. The SDPA organization, founded in 1994, has over 1,700 members and continues to grow. The main focus of the organization is to provide continuing medical education to its members, form leadership structure, act as an advocate for members, and develop resources for the evaluation and hiring of Physician Assistants. Medelita is proud to have this affiliation with such a prestigious PA organization, as the founder is also a PA. The partnership is extremely complimentary.

Dermatology PAs find Medelita lab coats to be especially professional and classy, with a comfortable, ergonomic fit. With a fit similar to professional clothing, and styling and workmanship improvements throughout, doing procedures from multiple angles and positions is now easier and more comfortable. Coupled with the Advanced Dual Action Teflon® fabric protector, the performance of the lab coats is ideal for those clinicians who are at higher risk for exposure to bodily fluids or other spills. Medelita high-performance lab coats help to ensure a clean, bright white appearance by preventing soil and stains from setting in, and also allowing a fluid barrier.  They wash better than any other lab coat available, and stay bright white.

“We recently received a testimonial from a dermatology PA who said that on the very first day that she received her Medelita lab coat, blood splashed onto the sleeve during a procedure,” shares Lara Manchik, PA-C and founder. “She simply “brushed” it off with a hand towel – with no trace of it left on the surface.  Her supervising MD immediately asked where he could get a similar coat of the same performance quality.”

Via EPR Network
More Healthcare press releases

Summer Sun Sees Demand for Cosmetic Non-surgical Treatments

Top treatments this season include Botox injections, stretch mark removal, laser hair removal, skin peels and microdermabrasion.

With summer fast approaching The Harley Medical Group, the UK’s leading cosmetic surgery provider, has seen an increase in bookings for non-surgical treatments, as many patients get bikini-body ready for the warmer months.

The Harley Medical Group offer a range of non-surgical treatments across their 31 clinics nationwide including stretch marks and scar removal, laser hair removal as well as Botox and skin peels to achieve fresher and more youthful skin.

Comments Lisa Littlehales, Nurse Counsellor at The Harley Medical Group: “As the weather warms up people start to think about their bodies and how they will look and feel come summer time. We offer a number of treatments to help people approach the season full of confidence. April is the perfect time to book a treatment at one of our clinics as it enables you to undertake a course of laser hair removal or stretch mark and scar removal in time for summer.”

Via EPR Network
More Healthcare press releases

Women’s Level One Weekend Mindfulness Retreat, Rome, GA: June 17-19, 2011

“It’s almost normal today to feel as if you have ADD (Attention Deficit Disorder). We’re all suffering from stimulation overload and sensory exhaustion” says Pamela Barge, MS, LPC, NCC, Director of Personal Coaching & Psychotherapy Associates, LLC dba Personal Coaching & Psychotherapy for Women. This is what led Pam to put together her special weekend mindfulness retreats which she offers to professional colleagues as sanctioned continuing education programs as well as to the general public.

“These special weekends are offered as a special time away…a time to check out from the world and into ourselves for a time”. With sunrise and candlelight yoga, tai chi, delicious plant based meals, mindful consideration of what the Buddhists call ‘Noble Silence’, opportunities to practice sitting and walking meditation as well as stimulating group discussions with like-minded folks, this may be just the ticket to slow things down and to become more connected with yourself and with life.

Pamela Barge, LPC, has a background as a marketing executive and independent entrepreneur. This business background together with her training as a therapist and her own practice of mindful meditation gives her therapy and coaching practice its unique flavor. The theoretical foundation of her work is founded upon the tenets of mindfulness and the evidence-based works of such folks as Jon Kabat Zinn, PhD, founder of the Stress Reduction Clinic at the University of Massachusetts, Thich Nhat Hanh, world renowned and revered Buddhist monk who was nominated for the Nobel Peace Prize by Martin Luther King, Sharon Salzberg of the Insight Meditation Society in Barre, Massachusetts and His Holiness the XIV Dalai Lama.

Each retreat is limited to fifteen attendees. For more information, to see an individual retreat schedule as well as her 2011 Retreat Calendar or to make a reservation, visit her website at www.womenscoaching.biz or phone Pam at 678-230-8127.

Via EPR Network
More Healthcare press releases

Medelita Gives Back With Newest Affiliation

Medelita®, lab coat manufacturer and online retailer upscale men’s and women’s medical apparel, is pleased to announce their latest affiliation with the American Academy of Cosmetic Dentistry. Currently AACD members who make purchases through Medelita.com receive a 10% discount. In addition to this member discount, the premier lab coat and medical scrubs retailer will donate 5% off every purchase to the Give Back a Smile Program.

The AACD is dedicated to advancing excellence in cosmetic dentistry and encouraging high standards in patient care. The American Academy of Cosmetic Dentistry Charitable Foundation’s (AACDCF) mission is to assist in rebuilding the lives and dignity of survivors of domestic violence through compassionate cosmetic dental services and support programs. Our program provides restorative and cosmetic dentistry in the smile zone at no cost to qualified survivors through our nationwide network of volunteer cosmetic dentists and our support team of laboratories and dental manufacturers. Similarly, Medelita also holds elevated standards in providing professional, sophisticated, technically advanced apparel to the dentists, physicians, and surgeons they serve. Thus, the affiliation is a synergistic fit.

AACD members are able to choose from four dental-specific lab coats, or from seven additional lab coats and multiple colors of men’s and women’s scrubs, all visible at www.medelita.com. In addition to lab coats and scrubs, Medelita offers the very best clogs available to healthcare professionals. Medelita not only provides the essentials, but specifically designs dental-specific lab coats with cuffed sleeves and optional closure to the neck. By following OSHA recommendations for garment construction, and combining those features with quality construction and Advanced Dual Action Teflon® performance fabric, members appreciate Medelita as a thoughtful uniform ideal for dentists.

Members of the AACD will receive a 10% discount on all purchases made through Medelita by entering the promotional code GBSMILE. In addition, with every purchase made, Medelita will donate 5% to the Give Back a Smile Program. This program founded by the AACD was developed in recongnition of addressing the needs in the communities of AACD members. Volunteer cosmetic dentists and laboratory technicians agree to restore the broken and damaged teeth of survivors of intimate partner violence at no cost. More than 1,000 U.S applicants have received services from this program.

Via EPR Network
More Healthcare press releases

Medelita Providing In-House Embroidery Services

Medelita®, breakthrough performance maker in medical scrubs and lab coats for both men and women, announces that all embroidery services are now completed in-house. With two top-of-the-line embroidery machines and an expert embroidery team, the premier medical apparel retailer is able to provide high quality customization without the need to outsource.

Medelita, known for their superior quality physician scrubs and performance lab coats has always offered custom embroidery services for their clients. Previously outsourced, resulting in lengthy lead times and frustrating delays, customers can now opt for Medelita in-house customization options and experience less than 10 day completion on any lab coat or medical scrub top embroidery order. Embroidery is completed by artisans with complex digitization experience, resulting in the very best quality logo and name & title stitching in the medical apparel industry. Custom options include name & title embroidery up to 3 lines, professional organization logo embroidery, and custom logo design for private practices, hospitals or university settings.

The fine quality and careful precision that goes into every stitch is consistent with the high standards that Medelita maintains on their lab coats and scrubs. Founder Lara Manchik, PA-C, states “Embroidery is the closest thing to wearing your diploma. For that reason it must be perfectly displayed, as a symbol of prestige and aptitude.”

With lab coat embroidery prominently displayed as acknowledgement of one’s educational achievements, physicians and surgeons can feel distinguished and elegant with professional embroidery from Medelita.

By conducting all embroidery services in-house, Medelita can ensure that the finished product is met to their high standards. All embroidered items go through a triple-check process that boasts an error rate of less than 0.01%. No other medical apparel company performs all these types of services strictly in-house, nor with such high standards or resultant quality.

Via EPR Network
More Healthcare press releases

LASIK Eye Surgery Information & Surgeon Directory Appoints 2011 Editorial Advisors

The LASIK laser eye surgery information and LASIK surgeon directory website seewithlasik.com is pleased to announce that three additional cornea and LASIK surgeons have been appointed as 2011 Editorial Advisors.

“We are extremely grateful to the members of the 2010 seewithlasik.com Editorial Advisory Board who were so helpful in guiding us in providing insight and guidance into the selection of new topics and new information to present to patients regarding Laser Eye Surgery for Laser Vision Correction such as LASIK. For our 2011 advisor selection we identified the possibility of broadening our clinical scope by reaching out for the assistance of eye surgeons Leslie Doctor, M.D., Ravi Shah, M.D. and JoAnn Chang, M.D, all fellowship trained cornea and refractive surgeons,” said Katherine Carlisle, Managing Partner of seewithlasik.com.

Leslie Doctor, M.D. is a Cornea, Cataract & LASIK Surgeon in Fairfield County, Connecticut. Dr. Leslie Doctor received her medical degree with honors from The Ohio State University School of Medicine followed by a residency in ophthalmology and a Fellowship in Cornea and Refractive Surgery at The Ohio State University Medical Center. She continues her dedication to the education of eye physicians and surgeons through her appointment as a Clinical Assistant Professor of Ophthalmology at the Yale University School of Medicine in New Haven, Connecticut where she teaches advanced techniques of cataract surgery & intraocular lens implantation (IOL) to new eye surgeons. To view Dr. Doctor’s biography, please visit doctor-cataract-lasik-connecticut.com.

Ravi Shah, M.D. is a Cornea, Refractive & LASIK Surgeon in Portland, Maine at Eyecare Medical Group. Dr. Shah is a corneal specialist specializing in the diagnosis and treatment of corneal disease, corneal transplantation using traditional cornea surgery and transplant techniques as well as advanced techniques such as DSAEK (Decement’s Stripping Automated Endothelial Keratoplasty), and laser eye surgery for laser vision correction such as LASIK. Dr. Shah received his medical degree and completed a residency in ophthalmology at the University of Medicine & Dentistry of New Jersey (UMDNJ) followed by a Fellowship in Cornea and Refractive Surgery at the Cleveland Clinic Cole Eye Institute. To view Dr. Shah’s biography, please visit  eyecaremed.com.

Via EPR Network
More Healthcare press releases

Mayo Clinic Leader Joins UHS As President

University Health Systems of Eastern Carolina announced today that Dr. David Herman, a physician leader with the Mayo Clinic, will join UHS as president of the health care system.

Herman currently serves as medical director of the Mayo Clinic Affiliated Practice Network. As UHS president, Herman will be responsible for the health system, including coordinating and integrating health care at all levels of service, from free community screenings and physician practices to local hospitals and tertiary medical care.

Dave McRae, chief executive officer of UHS, said the organization has been moving for some time toward a more integrated system of health care delivery, and Herman will lead that integration.

“Dr. Herman has experience in building a mature, integrated health care delivery system,” McRae said. “His leadership at one of the world’s premiere health care systems will guide us as we prepare for this new world of health care for eastern North Carolina.”

Herman has significant expertise and experience consolidating and integrating physician practice networks, developing formal relationships with national and regional provider groups and building operational structures to serve those relationships.

As director of the Employee and Community Health Program at Mayo Clinic Rochester, Herman worked to develop programs in the community and in the public school system that address chronic illnesses and diseases.

Herman currently is a consultant in ophthalmology at Mayo Clinic and a professor of ophthalmology in the Mayo Clinic College of Medicine. He has more than 90 peer-reviewed publications and served as a principle investigator for an NIH grant studying ocular hypertension and glaucoma.

Herman said his decision to relocate to eastern North Carolina was based on great potential to unify a system of care that will be critical in the coming years.

“Few organizations are in the unique position of being able to build a true system of care to address the care needs of the populations they serve,” Herman said. “I am impressed with the people who make up UHS, and I am eager to work with the team to design, execute and demonstrate this new system of health care. I am honored and eager to have a chance to serve in this new capacity.”

Herman currently serves on the board of directors for the Mayo Health System, the board of directors for the Western Region of the Mayo Health System, and is a member of the management team of Mayo Clinic. Herman also served as chair of the Mayo Clinic Rochester Clinical Practice Committee, an executive position similar to the role he will assume at UHS.

He currently serves on the board of directors and the Strategy and Personnel Committees for the Institute of Clinical Systems Improvement, directing the development of guidelines and protocols of care for preventive services, acute and chronic care.

Herman was recently named to the board of trustees of Ronald McDonald House Charities, the international charity that sponsors and supports Ronald McDonald Houses worldwide.

Via EPR Network
More Healthcare press releases

Housing Market Crash and Rising Medical Costs, Is There A Connection?

As millions of American homeowners know, the housing market crash was fueled by inflated home values and bank loans that were high above the equity or actual value of “underwater” homes. According to Trisha Lotzer, JD., health-care attorney and CEO of Physis, Inc., a similar threat for banks, borrowers and owners of many of the nation’s medical, dental, optometry and veterinary practices must be averted.

Like residential real estate, medical practices may be marketed and sold by brokers. Brokers in the business of selling medical practices commonly charge 7-12% commission. The commission alone can add $80,000 to $2,000,000 to the purchase price, depending on the size of the facility–and drive up the bank note accordingly.

Like real estate agents, the job of the practice broker is to get the seller the highest selling price possible. Unlike real estate agents, however, brokers are often the only ones who value the practices they have for sale–giving them a built in incentive to inflate the value of practices and increase their commission. Ross Landreth, MBA, explains that the problem occurs when a practice is arbitrarily valued, purchased and financed at $1,500,000, but only has an actual fair market value (per USPAP approved valuation standards) of $850,000. This could mean that the practice does not cash-flow at $1,500,00 and that the new purchasers would have to raise the price of services in order to maintain profitability and pay back the bank note. This increase in the cost of health care does not increase the earnings of the practice owners or physicians but is passed along to patients and insurance providers.

Via EPR Network
More Healthcare press releases

The Harley Medical Group reports boom in post-baby breast surgery

The Harley Medical Group, the UK’s leading cosmetic surgery provider, has reported a rise in mums booking surgical treatments post-pregnancy to help them combat the effects of pregnancy. The most popular treatment amongst new mums is breast augmentation, with bookings up 31% year-on-year.

The Group, which treats thousands of women a year across their 31 clinics, has seen more new mothers turning to surgical options to help regain shape and body confidence following pregnancy. Liposuction is also popular, up 27% year-on-year, and tummy tuck bookings are also up 15% year-on-year.

Comments Lisa Littlehales, specialist nurse counsellor at The Harley Medical Group:
“Many mothers find their breasts change after giving birth – often they notice a decrease in size or difference in shape following pregnancy and breast feeding. This can affect confidence and self-esteem. Lots of women are realising the surgical options available to them – breast augmentation helps mothers regain the shape and fullness of the breast, helping them feel more feminine again.”

Marco Moraci, surgeon at The Harley Medical Group, said: “Breast surgery is the most popular procedure amongst women, particularly new mums. The operation takes around an hour and a half, and patients are required to wear a supportive bra for the three months following. Prior to the surgery, we’ll help the patient choose the right size implant for their shape to ensure they achieve the look they desire.”

The procedure consists of a small incision being made in the crease of the underside of the breast, the armpit or lower edge of the areola. Once the incision is made, a pocket will be created for the implant to lie in. This may be either beneath the muscle or beneath the breast tissue.

Says, Michelle Denney who had a breast augmentation at The Harley Medical Group:
“After my pregnancy it became obvious that my breasts weren’t going to return to the shape and size they were before I fell pregnant. I decided to have surgery at The Harley Medical Group as my breasts were affecting my confidence and I longed to find a shape which worked for my new post-baby body. I am thrilled with the results and I haven’t looked back”.

For further information please visit www.harleymedical.co.uk.

Via EPR Network
More Healthcare press releases

Medical Innovation Protection Stressed in EU-India Free Trade Agreement Talks

The Financial Express published an article on the Free Trade Agreement (FTA) talks that continue between the European Union (EU) and India. One of the most discussed and disagreed upon parts of the proposed FTA involves the need for protecting the intellectual property of pharmaceutical companies in order to promote medical innovation and investment in the development of new medicines and research. This disagreement about whether data exclusivity in the pharmaceutical sector should be included has resulted in the delay of finalizing the FTA.

Pharmaceutical companies rely on data exclusivity to protect the investment made in developing the medication that is used throughout the world. Millions of dollars are spent on clinical trials to prove the safety and effectiveness of these drugs. These exclusive rights prevent competitors from obtaining marketing licenses for lower cost versions of these drugs.

Global Health Progress (GHP) is committed to being part of the effort to create a sustainable health care system that includes improving access to health care and continuing medical innovation and progress for all people. While the pharma industry is divided on the issue, GHP supports efforts to improve regulations protecting pharmaceutical companies’ intellectual property. Without this protection, the funding of studies that bring these medications to market could suffer.

Improving health care systems and access to medicines, especially in the developing world, requires multifaceted approaches and solutions. Research-based biopharmaceutical companies are active partners in some of the largest and boldest health initiatives that explore new and effective ways to provide treatment, care and education to millions of people in developing countries.

About Global Health Progress:
Global Health Progress also supports efforts to raise awareness and mobilize resources to address health challenges in the developing world by bringing local leaders together with international health experts, policymakers, donor governments, and the private sector.

www.globalhealthprogress.org;

twitter.com/globalhealth;

facebook.com/pages/Global-Health-Progress/124850684219049;

linkedin.com/groups?home=&gid=2972068

Via EPR Network
More Healthcare press releases

Eye Care – The Next Big Thing In Kerala’s Medical Travel Industry

Medical travel industry in Kerala is all set to broaden its scope through micro cataract surgery and support services for cataract patients. It is considered as the next big thing after Ayurveda and dentistry in the domain of medical travel in Kerala. Micro Cataract Surgery is gaining the attention of cataract patients. Apart from its efficiency, after 24 hours of this surgery, patients are able to return to their normal life. And what more; this quick recovery period inspires many to opt for holidays in God’s Own Country.

Interestingly, Mulamoottil Eye Hospital (MEH), one of the pioneers in eye care is offering micro cataract surgery at Asia’s lowest cost – INR 30,000 (US $700). Besides the affordable cost of the surgery, MEH offers free accommodation for two days.

“Unlike conventional cataract surgery, the advanced micro cataract surgery at Mulamoottil Eye Hospital uses 0.9 mm tip inside the eye. Patients enjoy full recovery after 24 hours, enabling them to take head bath, go for office work, drive car, apply medicine on their own and even take a flight,” says Dr. Ashley Thomas Jacob, Medical Director of MEH, which has a tradition of 125 years in eye care.

Mulamoottil Eye Hospital is the largest eye hospital in Kerala and is located at Kozhencherry, a small town in the Pathanamthitta district of Kerala, India. MEH is also the pioneers in Customized Cataract Surgery. The hospital also offers precise surgeries for presbyopia, myopia (short-sight) diabetic eye disease etc. with shortest post-surgical recovery period. It also conducts research and training activities in ophthalmology.

By virtue of its location, Mulamoottil Eye Hospital is close to some of the captivating travel destinations in Kerala that include Kumarakom, Alappuzha, Fort Kochi, Munnar, Periyar etc. And this makes patients from outside Kerala and non-resident Indians to club holidaying in Kerala, popular as ‘God’s Own Country’ with their visit for eye treatment; especially after undergoing micro cataract and customized cataract surgeries.

Via EPR Network
More Healthcare press releases

Global Health Progress Amplifies Report Calling for Funding Products to Fight Neglected Tropical Diseases

The third-annual Global Funding of Innovation for Neglected Diseases (G-FINDER) survey was released last week revealing both good and bad news for the funding of neglected diseases in the developing world. In a press release issued by Policy Cures, an independent group providing research and analysis for those involved in the creation of new pharmaceuticals for neglected diseases, the group reveals that while funding for neglected diseases has increased, funding for new products has decreased.

Funders appear to be focusing more of their money toward traditional basic research. This shift has caused a $50 million drop in funding for Product Development Partnerships (PDP), non-profit organizations that partner with external organizations to drive product development for neglected diseases, including neglected tropical diseases.

Report author Dr Mary Moran, Director of Policy Cures warns funders not to “take their eyes off the ball” in the press release, stating that while the increase in funding is encouraging it is important that the funds are spent wisely.

Global Health Progress has worked with partner groups to encourage and sustain funding for the research and development of new products. The innovative research and development (R&D) of new drugs and vaccines is a critical component of improving health care and combating epidemics of neglected tropical diseases in developing countries. There are no vaccines or cures for some widespread and life threatening diseases such as malaria, while existing treatments for diseases such as tuberculosis are becoming less effective due to drug resistance.

Read the full press release from Policy Cures here:
http://globalhealthprogress.org/mediacenter/wp-content/uploads/G-FINDER_Year_3_media_release.pdf,
or read the G-FINDER report on the Policy Cures website:
http://www.policycures.org/downloads/g-finder_2010.pdf.

Via EPR Network
More Healthcare press releases